战争与和平:探索微生物防御系统作为新抗菌疗法的来源
Paul J Dyson1, Ibrahim M Banat2, Gerry A Quinn2
1Medical School, Institute of Life Sciences, Swansea University, Swansea, United Kingdom.
Frontiers in pharmacology
|January 22, 2025
概括
世界卫生组织指出,由于耐药性,迫切需要抗生素. 本综述涵盖了新的抗生素和对抗沙门氏菌和西格拉菌等耐药病原体的可持续策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁,新药开发有限.
- 世界卫生组织 (WHO) 已经优先考虑了关键的多抗药性病原体,包括耐诺类型沙门氏菌,耐诺类型西格拉菌和耐万科米辛类型菌.
- 现有的审查广泛涵盖这些病原体,但往往忽视了将传染过程和抗生素生态学的知识转化为可持续治疗的基本差距.
研究的目的:
- 审查新批准的抗微生物药物 (2014年以来) 对世卫组织优先考虑的多药耐药病原体有效.
- 探索如何理解传染病的进步和抗生素生产的分子生态学可以为可持续的治疗策略提供信息.
- 面对不断升级的抗生素耐药性,解决对新型治疗方法的关键需求.
主要方法:
- 最近批准的抗微生物药物的叙述性审查.
- 综合有关关键病原体感染过程的当前知识.
- 探索抗生素生产的分子生态及其潜在应用.
主要成果:
- 确定最近批准的抗微生物药物,为治疗由世卫组织优先病原体引起的感染提供潜在的解决方案.
- 讨论利用分子生态学和疾病过程洞察力的挑战和机遇,以制定可持续的抗微生物战略.
- 承认随着任何新的抗生素使用,未来耐药性发展的不可避免风险.
结论:
- 新批准的抗生素为应对紧急的多药耐药病原体提供了即时的选择.
- 更深入地了解微生物生态和疾病发病因子对于开发抗生素耐药性的长期,可持续的解决方案至关重要.
- 将新药疗法与生态洞察力相结合,对于未来的传染病管理至关重要.
相关概念视频
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Surface Membrane Barriers
1.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.0K
Antimicrobial Proteins
884
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
884
Defense Mechanism Against Infection
6.3K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
6.3K
Antibiotic Selection
52.2K
Overview
52.2K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K


